Knowstox

Fundamentals snapshot

Diversified Healthcare Trust

DHC · NMS · Real Estate · REIT - Healthcare Facilities

Current price

$8.12

52-week range

$3.92 - $9.66

Market cap

$1.97B

One-glance verdict

Within fair range

$7.66 our estimate vs market $8.12

Wall Street consensus: $10.15 (32.5% higher than our fair-value estimate)

Balance sheet

Distressed

-0.14x Concerning

Net debt $2.30B. Interest coverage shows how many times profit covers the interest bill.

What this company does

Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, or REIT (a company that owns a collection of income-producing properties), which focuses on healthcare buildings across the U.S. It primarily makes money by collecting rent from the tenants (the businesses that operate there) in its senior housing communities, medical offices, and life science labs. This is important because the company's success is tied to the growing need for healthcare facilities as the population ages.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $-26.11M FY2024 Q4 $-48.54M FY2025 Q1 $-42.89M FY2025 Q2 $18.84M FY2025 Q3 $-89.84M FY2025 Q4 $-52.54M FY2026 Q1 $-26.82M FY2026 Q2 $14.20M
Revenue $365.39M
Net income $-37.42M
Diluted EPS -0.16
Operating cash flow $38.38M
Free cash flow $14.20M
Revenue $366.47M
Net income $-43.27M
Diluted EPS -0.18
Operating cash flow $8.34M
Free cash flow $-26.82M
Revenue $379.57M
Net income $-21.22M
Diluted EPS -0.09
Operating cash flow $-20.11M
Free cash flow $-52.54M
Revenue $388.71M
Net income $-164.04M
Diluted EPS -0.68
Operating cash flow $-49.28M
Free cash flow $-89.84M
Revenue $382.71M
Net income $-91.64M
Diluted EPS -0.38
Operating cash flow $53.02M
Free cash flow $18.84M
Revenue $386.86M
Net income $-8.99M
Diluted EPS -0.04
Operating cash flow $-3.24M
Free cash flow $-42.89M
Revenue $379.62M
Net income $-87.45M
Diluted EPS -0.37
Operating cash flow $18.20M
Free cash flow $-48.54M
Revenue $373.64M
Net income $-98.69M
Diluted EPS -0.41
Operating cash flow $21.13M
Free cash flow $-26.11M

Is it cheap or expensive?

Fair value $7.66 vs current price $8.12

Wall Street consensus is the average analyst price target: $10.15 (32.5% higher than our fair-value estimate).

Our most-likely fair value is $7.66 a share — about 5.7% away from today's price of $8.12, so the stock currently looks fairly priced.

fair

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 9.0% · Discount 12.7% · Terminal 2.5%

$7.66

Bear

Growth 2.5% · Discount 12.7% · Terminal 2.5%

$2.76

Bull

Growth 19.0% · Discount 12.7% · Terminal 2.5%

$19.05

Is it drowning in debt?

Distressed

Net debt $2.3B. Interest coverage -0.1x.

Net debt $2.30B
Interest coverage -0.14x

Diversified Healthcare Trust's profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here.

Distressed
Worse cushion Baseline Better cushion
DHC BASELINE Diversified Healthcare Trust

Total debt $2.42B Interest coverage -0.14x This is the baseline the peer rows are being compared against.

Total debt $779.49M Interest coverage 3.53x This peer still has a real interest-payment cushion, while DHC does not.

Total debt $9.70B Interest coverage 1.05x This peer still has a real interest-payment cushion, while DHC does not.

Total debt $1.28B Interest coverage 3.53x This peer still has a real interest-payment cushion, while DHC does not.

Total debt $2.63B Interest coverage 2.35x This peer still has a real interest-payment cushion, while DHC does not.

What you should know

The case for and against DHC

2 Rewards 1 Risk

Rewards

  • Free cash flow was positive in 4/10 years.
  • Dividend yield is 0.5% with 27-year payout history.

Risks

  • Return on equity was -15.5% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
Forward P/E
-18.67x
P/B
1.24x
P/S
1.31x
EV/EBITDA
19.34x
PEG ratio
1.89x

Profitability

How much profit each dollar creates

Gross margin
18.6%
Operating margin
-0.1%
Net margin
-17.7%
ROE
-15.5%
ROA
-0.4%

Health

Liquidity and balance-sheet strength

Debt / equity
1.53x
Current ratio
6.65x
Quick ratio
6.00x
Total debt
$2.42B
Total cash
$116.85M

Growth

How the business has been compounding

Revenue TTM
$1.50B
Revenue 5Y CAGR
2.7%
EPS TTM
-1.11
EPS 5Y CAGR

Cash flow

How much cash the business throws off

Operating CF TTM
$-22.67M
Free CF TTM
$-166.44M
FCF margin
-11.1%

Dividend

Shareholder payout

Yield
0.5%
Payout ratio
2.3%
Last ex-div date
2026-07-20